Exploring Ep 6 Identifying Nonmetastatic Crpc
Exploring Ep 6 Identifying Nonmetastatic Crpc reveals several interesting facts.
- Judd W. Moul, MD; Julie Graff, MD; and Charles J. Ryan, MD, reflect upon the most relevant changes in the current landscape of ...
- Matthew R. Smith, MD, PhD, defines
- Charles J. Ryan, MD, highlights clinical trials evaluating therapies for
- Raoul S. Concepcion, MD, FACS; Neal D. Shore, MD, FACS; Daniel George, MD; and Alec Koo, MD, define castration-resistant ...
- Trials are underway to investigate the role of nonsteroidal antiandrogens in
In-Depth Information on Ep 6 Identifying Nonmetastatic Crpc
Key opinion leaders define Judd W. Moul, MD, provides a background on Nonmetastatic Judd W. Moul, MD; Julie Graff, MD; and Charles J. Ryan, MD, highlight which approaches most excite them in the future treatment ...
Physicians describe when to start androgen deprivation therapy in patients with prostate cancer and discuss the consequences of ...
Stay tuned for more updates related to Ep 6 Identifying Nonmetastatic Crpc.
